Results 161 to 170 of about 1,709,620 (289)
David B Nelson, Yevgenia Y Fomina Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, TX, USACorrespondence: David B Nelson, Division of Maternal-Fetal Medicine ...
Nelson DB, Fomina YY
doaj
Accelerated Approval Seen as Triumph and Roadblock for Cancer Drugs [PDF]
Elizabeth J. Susman
openalex +1 more source
Altered Dynamic Functional Network Connectivity in Post‐Stroke Aphasia
ABSTRACT Objective Previous studies examining post‐stroke aphasia (PSA) patients via resting‐state functional magnetic resonance imaging (rs‐fMRI) have predominantly focused on static functional connectivity. In contrast, the current investigation aims to elucidate the alterations in dynamic functional network connectivity (dFNC) among PSA patients ...
Guihua Xu +6 more
wiley +1 more source
Modernising the US FDA's Accelerated Approval pathway.
D. J. Benjamin, M. Lythgoe
semanticscholar +1 more source
Visual Recovery Reflects Cortical MeCP2 Sensitivity in Rett Syndrome
ABSTRACT Objective Rett syndrome (RTT) is a devastating neurodevelopmental disorder with developmental regression affecting motor, sensory, and cognitive functions. Sensory disruptions contribute to the complex behavioral and cognitive difficulties and represent an important target for therapeutic interventions.
Alex Joseph Simon +12 more
wiley +1 more source
Challenges in accelerated approvals for gene therapies [PDF]
Rafael Escandon, John D. Lantos
openalex +1 more source
ABSTRACT Background Poststroke fatigue (PSF) and frailty share substantial overlap in their manifestations, yet previous research has yielded conflicting results due to the use of heterogeneous frailty assessment tools. Objective To evaluate the independent impact of frailty on PSF using a unified measurement system (Tilburg Frailty Indicator, TFI ...
Chuan‐Bang Chen +6 more
wiley +1 more source
Impact of accelerated review policy on portfolio planning of vaccine companies
BackgroundWith the introduction of the accelerated drug review policy in China, the clinical research and development time and the review and approval time of drugs have been shortened accordingly. Especially under the influence of the COVID-19 pandemic,
Guicui Liu, Zhe Huang, Zhe Huang
doaj +1 more source

